Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-055351
Abstract: Introduction There is evidence that low-dose naltrexone (LDN; read more here.
Keywords: innova study; trial; naltrexone ldn; dose naltrexone ... See more keywords